These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 20628598
21. Effects of melatonin receptor 1B gene variation on glucose control in population from Bosnia and Herzegovina. Semiz S, Dujic T, Velija-Asimi Z, Prnjavorac B, Bego T, Ostanek B, Marc J, Causevic A. Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):350-5. PubMed ID: 24710643 [Abstract] [Full Text] [Related]
22. Association of GCK (rs1799884), GCKR (rs780094), and G6PC2 (rs560887) Gene Polymorphisms with Type 2 Diabetes among Malay Ethnics. Ansari N, Ramachandran V, Mohamad NA, Salim E, Ismail P, Hazmi M, Mat LNI. Glob Med Genet; 2023 Jan; 10(1):12-18. PubMed ID: 36703777 [Abstract] [Full Text] [Related]
23. Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes. Tracz A, Madzio J, Gnys P, Malachowska B, Borowiec M, Wyka K, Jarosz-Chobot P, Mysliwiec M, Szadkowska A, Mlynarski W, Fendler W, PolPeDiab Study Group. Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):503-9. PubMed ID: 24918535 [Abstract] [Full Text] [Related]
24. Association of the rs10830963 polymorphism in MTNR1B with fasting glucose levels in Chinese children and adolescents. Song JY, Wang HJ, Ma J, Xu ZY, Hinney A, Hebebrand J, Wang Y. Obes Facts; 2011 Oct; 4(3):197-203. PubMed ID: 21701235 [Abstract] [Full Text] [Related]
25. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program. Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC, Diabetes Prevention Program Research Group. PLoS One; 2012 Oct; 7(9):e44424. PubMed ID: 22984506 [Abstract] [Full Text] [Related]
26. Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels. Bouatia-Naji N, Bonnefond A, Baerenwald DA, Marchand M, Bugliani M, Marchetti P, Pattou F, Printz RL, Flemming BP, Umunakwe OC, Conley NL, Vaxillaire M, Lantieri O, Balkau B, Marre M, Lévy-Marchal C, Elliott P, Jarvelin MR, Meyre D, Dina C, Oeser JK, Froguel P, O'Brien RM. Diabetes; 2010 Oct; 59(10):2662-71. PubMed ID: 20622168 [Abstract] [Full Text] [Related]
27. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Sparsø T, Bonnefond A, Andersson E, Bouatia-Naji N, Holmkvist J, Wegner L, Grarup N, Gjesing AP, Banasik K, Cavalcanti-Proença C, Marchand M, Vaxillaire M, Charpentier G, Jarvelin MR, Tichet J, Balkau B, Marre M, Lévy-Marchal C, Faerch K, Borch-Johnsen K, Jørgensen T, Madsbad S, Poulsen P, Vaag A, Dina C, Hansen T, Pedersen O, Froguel P. Diabetes; 2009 Jun; 58(6):1450-6. PubMed ID: 19324940 [Abstract] [Full Text] [Related]
28. Two susceptible diabetogenic variants near/in MTNR1B are associated with fasting plasma glucose in a Han Chinese cohort. Kan MY, Zhou DZ, Zhang D, Zhang Z, Chen Z, Yang YF, Guo XZ, Xu H, He L, Liu Y. Diabet Med; 2010 May; 27(5):598-602. PubMed ID: 20536959 [Abstract] [Full Text] [Related]
29. Association of genetic variants with isolated fasting hyperglycaemia and isolated postprandial hyperglycaemia in a Han Chinese population. Kong X, Hong J, Chen Y, Chen L, Zhao Z, Li Q, Ge J, Chen G, Guo X, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Zhou Z, Shan G, Yang W. PLoS One; 2013 May; 8(8):e71399. PubMed ID: 23990951 [Abstract] [Full Text] [Related]
30. Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels. Baerenwald DA, Bonnefond A, Bouatia-Naji N, Flemming BP, Umunakwe OC, Oeser JK, Pound LD, Conley NL, Cauchi S, Lobbens S, Eury E, Balkau B, Lantieri O, MAGIC Investigators, Dadi PK, Jacobson DA, Froguel P, O'Brien RM. Diabetologia; 2013 Jun; 56(6):1306-16. PubMed ID: 23508304 [Abstract] [Full Text] [Related]
31. Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes. Chen G, Shriner D, Zhang J, Zhou J, Adikaram P, Doumatey AP, Bentley AR, Adeyemo A, Rotimi CN. PLoS One; 2022 Jun; 17(6):e0269378. PubMed ID: 35657990 [Abstract] [Full Text] [Related]
32. The associations of daylight and melatonin receptor 1B gene rs10830963 variant with glycemic traits: the prospective PPP-Botnia study. Haljas K, Hakaste L, Lahti J, Isomaa B, Groop L, Tuomi T, Räikkönen K. Ann Med; 2019 Feb; 51(1):58-67. PubMed ID: 30592226 [Abstract] [Full Text] [Related]
33. HbA1c-based diabetes diagnosis among patients with glucokinase mutation (GCK-MODY) is affected by a genetic variant of glucose-6-phosphatase (G6PC2). Borowiec M, Fendler W, Dusatkova P, Antosik K, Pruhova S, Cinek O, Mysliwiec M, Jarosz-Chobot P, Malecki MT, Mlynarski W. Diabet Med; 2012 Nov; 29(11):1465-9. PubMed ID: 22486180 [Abstract] [Full Text] [Related]
34. The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia. Heni M, Ketterer C, Hart LM, Ranta F, van Haeften TW, Eekhoff EM, Dekker JM, Boomsma DI, Nijpels G, Kramer MH, Diamant M, Simonis-Bik AM, Heine RJ, de Geus EJ, Schäfer SA, Machicao F, Ullrich S, Thamer C, Stefan N, Staiger H, Häring HU, Fritsche A. J Clin Endocrinol Metab; 2010 Dec; 95(12):E479-84. PubMed ID: 20826583 [Abstract] [Full Text] [Related]
35. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Huopio H, Cederberg H, Vangipurapu J, Hakkarainen H, Pääkkönen M, Kuulasmaa T, Heinonen S, Laakso M. Eur J Endocrinol; 2013 Sep; 169(3):291-7. PubMed ID: 23761423 [Abstract] [Full Text] [Related]
36. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study. Hishida A, Morita E, Naito M, Okada R, Wakai K, Matsuo K, Nakamura K, Takashima N, Suzuki S, Takezaki T, Mikami H, Ohnaka K, Watanabe Y, Uemura H, Kubo M, Tanaka H, Hamajima N. Endocr J; 2012 Sep; 59(7):589-99. PubMed ID: 22517333 [Abstract] [Full Text] [Related]
37. Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis. Li H, Xu R, Peng X, Wang Y, Wang T. Mol Biol Rep; 2013 Jun; 40(6):3935-42. PubMed ID: 23307301 [Abstract] [Full Text] [Related]
38. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Vaxillaire M, Cavalcanti-Proença C, Dechaume A, Tichet J, Marre M, Balkau B, Froguel P, DESIR Study Group. Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336 [Abstract] [Full Text] [Related]
39. A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Rönn T, Wen J, Yang Z, Lu B, Du Y, Groop L, Hu R, Ling C. Diabetologia; 2009 May; 52(5):830-3. PubMed ID: 19241057 [Abstract] [Full Text] [Related]
40. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Sparsø T, Andersen G, Nielsen T, Burgdorf KS, Gjesing AP, Nielsen AL, Albrechtsen A, Rasmussen SS, Jørgensen T, Borch-Johnsen K, Sandbaek A, Lauritzen T, Madsbad S, Hansen T, Pedersen O. Diabetologia; 2008 Jan; 51(1):70-5. PubMed ID: 18008060 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]